SNDL(NASDAQ) SNDL

Market Cap$340.17M

Since IPO (2019)-98%

5 Year-82%

1 Year-49%

1 Month+11%

Premium Feature

Moneyball Superscore

53/100

$1.37

+0.74%

+0.01Today

After hours$1.37+$0.00 (+0.37%)

SNDL last closing stock price
Metric	Price	Date
Last close	USD 1.37	2026-08-31

SNDL stock price return by period
Period	Price return	Price at period start	Period start date
1 week	+0.74%	USD 1.36	2026-08-24
1 month	+11.38%	USD 1.23	2026-07-31
3 month	-4.86%	USD 1.44	2026-06-02
Year to date	-17.47%	USD 1.66	2025-12-31
1 year	-48.88%	USD 2.68	2025-08-29
3 year	-22.16%	USD 1.76	2023-09-01
5 year	-82.19%	USD 7.69	2021-09-01
Since inception	-98.4%	USD 84.80	2019-08-01

SNDL Financials at a Glance

Market Cap

$340.17M

Revenue (TTM)

CA$928.39M

Net Income (TTM)

-CA$21.69M

EPS (TTM)

-$0.06

P/E Ratio

-22.20

Dividend

$0.00

Beta (Volatility)

1.38 (Average)

Dividend

$0.00

Beta (Volatility)

1.38 (Average)

Price

$1.37

Volume

343

Open

$1.35

Price

$1.37

Volume

343

Open

$1.35

Previous Close

$1.37

Daily Range

$1.34 - $1.38

52-Week Range

$1.17 - $2.89

Estimated Earnings Date

Nov 3, 2026

Dividend

$0.00

Beta (Volatility)

1.38 (Average)

Price

$1.37

Volume

343

Open

$1.35

Previous Close

$1.37

Daily Range

$1.34 - $1.38

52-Week Range

$1.17 - $2.89

Estimated Earnings Date

Nov 3, 2026

SNDL News

SNDL: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About SNDL

SNDL Inc. is a Canadian company focused on the cultivation, distribution, and sale of cannabis products. The firm operates through two segments: Cannabis Operations and Retail Operations, catering to the adult-use market.

Products and Services

Offers a variety of cannabis products, including dried flower and pre-rolled joints
Distributes inhalable products like vape cartridges under multiple brands
Operates a network of corporate-owned and franchised retail outlets

Growth Outlook

Revenue increased to CAD 235.77 million in Q2 2026, up from CAD 195.91 million in Q1 2026
Gross profit margin improved to 23.9% in Q2 2026 from 26.9% in Q1 2026
Strong cash position with CAD 183.21 million in cash and cash equivalents as of June 30, 2026

Financial Highlights

Net income for Q2 2026 was CAD -7.82 million, showing a reduction in losses
Operating cash flow of CAD 3.69 million in Q2 2026 indicates positive operational efficiency
Current ratio stands at 4.76, reflecting strong liquidity and financial health

AI Generated • Aug 18, 2026

Industry

Pharmaceuticals

Sector

Health Care

Employees

2,751

CEO

Zachary Ryan George

Website

www.sndl.com

Headquarters

Edmonton, AB T5S 1K6, CA

SNDL Financials

Key Financial Metrics (TTM)

Gross Margin

26.24%

Operating Margin

-1.70%

Net Income Margin

-2.34%

Return on Equity

-1.99%

Return on Capital

-0.35%

Return on Assets

-1.69%

Earnings Yield

-4.50%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$340.17M

Shares Outstanding

248.30M

Volume

343

Avg. Volume

1.94M

Financials (TTM)

Gross Profit

CA$243.57M

Operating Income

-CA$15.77M

EBITDA

CA$37.40M

Operating Cash Flow

CA$64.18M

Capital Expenditure

-CA$13.57M

Free Cash Flow

CA$50.61M

Cash & ST Invst.

CA$186.57M

Total Debt

CA$166.38M

SNDL Performance Analysis

SNDL annual revenue and year-over-year revenue growth by fiscal year
Fiscal year	Period end	Revenue	YoY growth
2022	2022-12-31	CAD 547,063,864	1122.0%
2023	2023-12-31	CAD 673,493,946	23.1%
2024	2024-12-31	CAD 671,878,695	-0.2%
2025	2025-12-31	CAD 677,312,492	0.8%

SNDL sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarter	Period end	QoQ growth
Q3	2025-09-30	-0.2%
Q4	2025-12-31	3.4%
Q1	2026-03-31	-22.4%
Q2	2026-06-30	20.3%

SNDL annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal year	Period end	Diluted EPS	YoY growth
2022	2022-12-31	CAD -1.12	15.1%
2023	2023-12-31	CAD -0.49	-56.5%
2024	2024-12-31	CAD -0.26	-46.2%
2025	2025-12-31	CAD -0.04	-83.3%

SNDL sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarter	Period end	QoQ growth
Q3	2025-09-30	-584.8%
Q4	2025-12-31	148.7%
Q1	2026-03-31	-249.4%
Q2	2026-06-30	21.3%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q2 2026YOY CHG

Revenue

CA$235.77M

-3.7%

Gross Profit

CA$56.35M

-16.6%

Gross Margin

23.90%

N/A

Market Cap

$340.17M

N/A

Market Cap/Employee

$123.65K

N/A

Employees

2,751

N/A

Net Income

-CA$7.82M

-371.1%

EBITDA

CA$6.62M

-64.5%

Quarterly Fundamentals

Name

Q2 2026YOY CHG

Total Cash

CA$186.57M

-11.9%

Total Debt

CA$166.38M

+10.5%

Accounts Receivable

CA$33.00M

+12.2%

Inventory

CA$136.21M

-1.0%

Long Term Debt

CA$130.28M

+11.2%

Short Term Debt

CA$36.09M

+8.2%

Return on Assets

-1.69%

N/A

Return on Invested Capital

-1.31%

N/A

Free Cash Flow

CA$1.90M

-52.9%

Operating Cash Flow

CA$3.69M

-39.7%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

EBSEmergent BioSolutions Inc.

EBSEmergent BioSolutions Inc.$6.10+3.21%

AKBAAkebia Therapeutics, Inc.

AKBAAkebia Therapeutics, Inc.$0.92+4.58%

SIGASIGA Technologies, Inc.

SIGASIGA Technologies, Inc.$3.14+2.61%

ORGOOrganogenesis Holdings Inc.

ORGOOrganogenesis Holdings Inc.$1.72-1.15%

EOLSEvolus, Inc.

EOLSEvolus, Inc.$9.09+2.36%

AQSTAquestive Therapeutics, Inc.

AQSTAquestive Therapeutics, Inc.$5.11+1.79%

ESPREsperion Therapeutics, Inc.

ESPREsperion Therapeutics, Inc.$3.18+0.00%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

WETOWetour Robotics

WETOWetour Robotics$5.48-0.04%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$71.92+0.00%

IBITiShares Bitcoin Trust

IBITiShares Bitcoin Trust$44.67+0.02%

INTCIntel

INTCIntel$89.51+0.00%

NVDANvidia

NVDANvidia$220.78+0.01%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF$9.97+0.11%

TLTiShares Trust - iShares 20+ Year Treasury Bond ETF

TLTiShares Trust - iShares 20+ Year Treasury Bond ETF$82.52-0.00%

Questions About SNDL

What is the current price of SNDL?

SNDL is trading at $1.37 per share.

What is the 52-week range for SNDL?

Over the past 52 weeks, SNDL has traded between $1.17 and $2.89.

How much debt does SNDL have?

As of the most recent reporting period, SNDL reported total debt of CA$117.27M.

How much cash does SNDL have on hand?

SNDL reported CA$143.29M in cash and cash equivalents in its most recent financial results.

What is SNDL’s dividend yield?

SNDL does not currently have a dividend yield.

SNDL(NASDAQ) SNDL

SNDL Financials at a Glance

SNDL News

5 Best Cannabis ETFs for 2026 and How to Invest

3 Reasons Why SNDL Might Be the Best Cannabis Stock of 2024 and 2025

SNDL Will Soon Pass a Big Milestone, But Is the Stock a Buy?

These Cannabis 3 Stocks Are Set to Soar This Summer and Beyond

Is SNDL Stock a Buy?

Here's How SNDL Stock Could Fly for the Rest of 2024 and Beyond

SNDL Stock Is Up 35% This Year. Here's Why It'll Go Higher.

Is SNDL Stock a Buy?

SNDL: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About SNDL

SNDL Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

SNDL Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About SNDL

What is the current price of SNDL?

What is the 52-week range for SNDL?

How much debt does SNDL have?

How much cash does SNDL have on hand?

What is SNDL’s dividend yield?

Premium Investing Services